UHS Beats Q2 Revenue but Slashes FY Profit Outlook on Higher Costs
UHS is trading near its 52-week low of $140.08 (3.3% above the low).
Summary
Universal Health Services posted a strong Q2 revenue beat at $4.64B vs. $4.58B consensus, with adjusted EPS of $5.98. However, the company cut its full-year adjusted EBITDA guidance to $2.610B-$2.717B and adjusted EPS to $22.28-$23.65, signaling margin pressure. The stock is trading near its 52-week low, and this guidance cut adds to concerns following the recent behavioral health division president's resignation and ongoing legal liabilities. The $100M Florida Medicaid benefit provided a one-time boost, but underlying cost trends appear to be eroding profitability. The aggressive $320M buyback in Q2 shows management confidence, but the lowered outlook will likely weigh on shares.
At the time of this announcement, UHS was trading at $144.75 on NYSE in the Life Sciences sector, with a market capitalization of approximately $9.6B. The 52-week trading range was $140.08 to $246.33. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.